Respirology

Article	Citations
Radiotherapy treatment for lung cancer: Current status and future directions	144
Global burden of sleep‐disordered breathing and its implications	141
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong	112
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact	69
One‐year follow‐up CT findings in COVID‐19 patients: A systematic review and meta‐analysis	68
Video‐assisted thoracoscopic surgery as the gold standard for lung cancer surgery	64
COVID‐19 infection and the broader impacts of the pandemic on healthcare workers	61
ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma	56
Natural history and mechanisms of COPD	47
Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*	46
Pulmonary alveolar proteinosis	45
Pulmonary toxicity of systemic lung cancer therapy	42
Current global perspectives on silicosis—Convergence of old and newly emergent hazards	40
Air pollution and the pandemic: Long‐term PM2.5 exposure and disease severity in COVID‐19 patients	40
Exercise training as part of lung cancer therapy	37
Occupational COPD—The most under‐recognized occupational lung disease?	36
Clusters of sleep apnoea phenotypes: A large pan‐European study from the European Sleep Apnoea Database (ESADA)	36
Pathophysiology of infection with SARS‐CoV‐2—What is known and what remains a mystery	35
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand	35
Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis	32
Stearic acid attenuates profibrotic signalling in idiopathic pulmonary fibrosis	31
Cost of hospitalization for bronchiectasis exacerbation in children	31
Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression	30
Delay or avoidance of routine, urgent and emergency medical care due to concerns about COVID‐19 in a region with low COVID‐19 prevalence: Victoria, Australia	30
Treatable traits in the NOVELTY study	30

Predictors of lung function trajectories in population‐based studies: A systematic review	30
Outcomes of protracted bacterial bronchitis in children: A 5‐year prospective cohort study	30
Muscle loss contributes to higher morbidity and mortality in COPD: An analysis of national trends	29
Lung cancer screening implementation: Complexities and priorities	29
Coagulation markers as predictors for clinical events in COPD	29
Global Initiative for Asthma Strategy 2021	28
Characteristics of bronchiectasis in Korea: First data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries	28
Prevalence and burden of breathlessness in Australian adults: The National Breathlessness Survey—a cross‐sectional web‐based population survey	27
Epidemiology, clinical spectrum, viral kinetics and impact of COVID‐19 in the Asia‐Pacific region	27
Abstracts	26
Risk prediction model in rheumatoid arthritis‐associated interstitial lung disease	26
Tocilizumab administration for the treatment of hospitalized patients with COVID‐19: A systematic review and meta‐analysis	25
Chest CT‐assessed comorbidities and all‐cause mortality risk in COPD patients in the BODE cohort	25
Bronchoscopy in COVID‐19 intensive care unit patients	25
Risk of cancer incidence in patients with idiopathic pulmonary fibrosis: A nationwide cohort study	25
Addition of zolpidem to combination therapy with atomoxetine‐oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial	24
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	24
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial	24
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy	24
Anti‐fibrotic effects of different sources of MSC in bleomycin‐induced lung fibrosis in C57BL6 male mice	24
Pulmonary rehabilitation in COVID‐19 pandemic era: The need for a revised approach	23
The role of SARS‐CoV‐2 antibodies in COVID‐19: Healing in most, harm at times	23
Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation	23
Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype	22
Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis	22
Respiratory surveillance for coal mine dust and artificial stone exposed workers in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*	21
Safe performance of diagnostic bronchoscopy/EBUS during the SARS‐CoV‐2 pandemic	21
Time‐resolved proteomic profiling of cigarette smoke‐induced experimental chronic obstructive pulmonary disease	21
Impact of early life exposures on COPD in adulthood: A systematic review and meta‐analysis	21
Mental health among healthcare workers during the COVID‐19 pandemic	21
Pharmacological treatment of stable chronic obstructive pulmonary disease	20
Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD: A randomized controlled trial	20
Ventilatory support at home for children: A joint position paper from the Thoracic Society of Australia and New Zealand/Australasian Sleep Association	20
Characteristics and long‐term survival of patients with chronic thromboembolic pulmonary hypertension in China	20
Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity	20
COVID‐19: Histopathological correlates of imaging patterns on chest computed tomography	19
Predictors of CPAP outcome in hospitalized COVID‐19 patients	19
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial	19
A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases	19
Face masks for community use: An awareness call to the differences in materials	19
Robotic‐assisted bronchoscopy versus CT‐guided transthoracic biopsy for diagnosis of pulmonary nodules	18
Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association*	18
Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*	18
Targeting the interleukin‐17 pathway to prevent acute respiratory distress syndrome associated with SARS‐CoV‐2 infection	18
Effects of chemical composition on the lung cell response to coal particles: Implications for coal workers' pneumoconiosis	18
Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers	18
COVID‐19 situation in Pakistan: A broad overview	18
Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ (FeNO) framework	18
Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study	17
Impact of COVID‐19 pandemic restrictions on the cardio‐respiratory health of New Zealanders	17

Risk factors for chronic cough in adults: A systematic review and meta‐analysis	17
Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data	16
Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Austra	16
Efficacy and safety of virtual bronchoscopic navigation with fused fluoroscopy and vessel mapping for access of pulmonary lesions	16
Characteristics, goal‐oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry	16
National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID‐19	16
Bronchoscopic treatments for early‐stage peripheral lung cancer: Are we ready for prime time?	16
Bronchoscopic interventions for severe emphysema: Where are we now?	16
Delayed access to lung cancer screening and treatment during the COVID‐19 pandemic: Are we headed for a lung cancer pandemic?	16
Effect of high‐flow nasal cannula oxygen therapy on exercise tolerance in patients with idiopathic pulmonary fibrosis: A randomized crossover trial	16
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	16
Bronchial thermoplasty versus mepolizumab: Comparison of outcomes in a severe asthma clinic	16
Respiratory management of infants with chronic neonatal lung disease beyond the NICU: A position statement from the Thoracic Society of Australia and New Zealand*	15
Challenges faced in managing adult asthma: A perspective from Asian countries	15
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases	15
Defining successful non‐invasive ventilation initiation: Data from a real‐life cohort	15
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	15
Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma–COPD overlap	15
Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden	14
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	14
Malignant pleural effusion survival prognostication in an Asian population	14
Multiplanar 3D fluoroscopy redefines tool–lesion relationship during robotic‐assisted bronchoscopy	14
Serum Krebs von den Lungen‐6 level in the disease progression and treatment of Mycobacterium avium complex lung disease	14
Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility	14
Serum amyloid A is a predictor for prognosis of COVID‐19	14
Universal public mask wear during COVID‐19 pandemic: Rationale, design and acceptability	14
Central airway collapse is related to obesity independent of asthma phenotype	14
Ultrathin bronchoscopic cryobiopsy of peripheral pulmonary lesions	13
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study‐2: Use of 2.5 mg alteplase as a starting intrapleural dose	13
Pulmonary functional MRI: Detecting the structure–function pathologies that drive asthma symptoms and quality of life	13
Relation between sex hormones and leucocyte telomere length in men with idiopathic pulmonary fibrosis	13
Cryotherapy in the paediatric airway: Indications, success and safety	13
Anti‐IgE therapy inhibits chemotaxis, proliferation and transformation of circulating fibrocytes in patients with severe allergic asthma	13
Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations	13
Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic	13
Letter from Indonesia	13
Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real‐world multicentre cohort	12
Long‐term impact of coal mine fire smoke on lung mechanics in exposed adults	12
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	12
Chronic obstructive pulmonary disease (COPD) mortality trends worldwide: An update to 2019	12
Preoperative staging of the mediastinum is an essential and multidisciplinary task	12
IL‐17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus	11
Multi‐institutional retrospective analysis of adverse events following rigid tracheobronchoscopy	11
CPAP telemonitoring can track Cheyne–Stokes respiration and detect serious cardiac events: The AlertApnée Study	11
Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis	11
Effect of surgical intervention for mild childhood obstructive sleep apnoea on attention and behavioural outcomes: A randomized controlled study	11
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis	11
Aerosol‐generating procedures in the COVID era	11
Pulmonary Daoyin as a traditional Chinese medicine rehabilitation programme for patients with IPF: A randomized controlled trial	11
Letter from Egypt	11
Contemporary narrative review of treatment options for COVID‐19	10
An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease	10
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia	10
Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults: ‘Swimming between the flags’	10
Genetic testing in interstitial lung disease: An international survey	10
Reduced exercise tolerance in mild chronic obstructive pulmonary disease: The contribution of combined abnormalities of diffusing capacity for carbon monoxide and ventilatory efficiency	10
Thoracic ultrasound as a predictor of pleurodesis success at the time of indwelling pleural catheter removal	10
Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID‐19	10
Letter from Singapore: The clinical and research response to COVID‐19	10
Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia	10
Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long‐term observational study	10
Cone‐beam computed tomography versus computed tomography‐guided ultrathin bronchoscopic diagnosis for peripheral pulmonary lesions: A propensity score‐matched analysis	9
Cigarette smoke extract decreased basal and lipopolysaccharide‐induced expression of MARCO via degradation of p300	9
Pleural effusions and pneumothorax: Beyond simple plumbing	9
Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: A pilot randomized controlled trial	9
Secondary infection among hospitalized COVID‐19 patients: A retrospective cohort study in a tertiary care setting	9
High turnover of types III and VI collagen in progressive idiopathic pulmonary fibrosis	9
Cardiovascular risks of children with primary snoring: A 5‐year follow‐up study	9
Radiological outcomes of whole lung lavage for artificial stone‐associated silicosis	9
Impact of recent catastrophic bushfires on people with asthma in Australia: Health, social and financial burdens	9
Home monitoring of lung function, symptoms and quality of life after admission with COVID‐19 infection: The HOMECOMIN' study	9
Periostin‐related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF‐2 signalling	9
Foetal growth restriction and asthma: Airway smooth muscle thickness rather than just lung size?	9
Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation‐wide population‐based study over 10 years	8
The HUNT study: Association of comorbidity clusters with long‐term survival and incidence of exacerbation in a population‐based Norwegian COPD cohort	8
Examining the impact of multilevel upper airway surgery on the obstructive sleep apnoea endotypes and their utility in predicting surgical outcomes	8
Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial	8
Endobronchial coil spring fiducial markers for CyberKnife® stereotactic body radiation therapy	8
Biologics for severe asthma—Which, when and why?	8
Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population‐based cohort study	8

Sleep‐disordered breathing was associated with lower health‐related quality of life and cognitive function in a cross‐sectional study of older adults	8
Pulmonary fibrosis in non‐mutation carriers of families with short telomere syndrome gene mutations	8
Promotion of physical activity after hospitalization for COPD exacerbation: A randomized control trial	8
Contribution of obesity to breathlessness in a large nationally representative sample of Australian adults	8
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis	8
Comparing recalled versus experienced symptoms of breathlessness ratings: An ecological assessment study using mobile phone technology	8
Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates	7
Animal models of COVID‐19 hyper‐inflammation	7
Comparisons of early and late presentation to hospital in COVID‐19 patients	7
Medical ethics in the era of COVID‐19: Now and the future	7
Inhaled corticosteroid is not associated with a poor prognosis in COVID‐19	7
Sarcoidosis‐related mortality and the impact of corticosteroid treatment: A population‐based cohort study	7
Increased physical activity reduces sleep disturbances in asthma: A randomized controlled trial	7
Longitudinal changes in total and regional body composition in patients with chronic obstructive pulmonary disease	7
Preoperative use of pirfenidone and reduced risk of postoperative severe respiratory complications in patients with idiopathic pulmonary fibrosis: Propensity score‐matched analysis using a nationwide	7
Laboratory performance of oronasal CPAP and adapted snorkel masks to entrain oxygen and CPAP	7
Thoracic manifestations of IgG4‐related disease	7
Bronchial thermoplasty: Redefining its role	7
Reversal of collateral ventilation using endoscopic polymer foam in COPD patients undergoing endoscopic lung volume reduction with endobronchial valves: A controlled parallel group trial	7
Why we still need drugs for COVID‐19 and can't just rely on vaccines	7
Bronchial thermoplasty: State of the art	7
Physical activity decline is disproportionate to decline in pulmonary physiology in IPF	7
The impact of regular bisoprolol on the response to salbutamol in asthma: A double‐blind randomized placebo‐controlled crossover trial	7
Contemporary Concise Review 2021: Interstitial lung disease	7
Acute cigarette smoke‐induced eQTL affects formyl peptide receptor expression and lung function	6
The needs and well‐being of severe asthma and COPD carers: A cross‐sectional study	6
Work‐related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia	6
Anti‐inflammatory reliever therapy in asthma: The evidence mounts but more is needed	6
Clinical utility of ventilatory and gas exchange evaluation during low‐intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension	6
Letter from Chile	6
Supranormal lung function: Prevalence, associated factors and clinical manifestations across the lifespan	6
Sleep and circadian health 6 months after critical COVID‐19 disease	6
Extrapulmonary manifestations of a telomere syndrome in patients with idiopathic pulmonary fibrosis are associated with decreased survival	6
Features of humidifier lung and comparison with summer‐type hypersensitivity pneumonitis	6
Variations in lung cancer care and outcomes: How best to identify and improve standards of care?	6
Interstitial lung diseases associated with mutations of poly(A)‐specific ribonuclease: A multicentre retrospective study	6
Are e‐cigarette use and vaping associated with increased respiratory symptoms and poorer lung function in a population exposed to smoke from a coal mine fire?	6
Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma	6
Role of endobronchial ultrasound strain elastography in the identification of fibrotic lymph nodes in sarcoidosis: A pilot study	6
COVID‐19 vaccine‐induced immunity: Head‐to‐head comparison of mRNA (BNT162b2) versus inactivated (CoronaVac) vaccines	6
Ipsilateral and contralateral hemidiaphragm dynamics in symptomatic pleural effusion: The 2nd PLeural Effusion And Symptom Evaluation (PLEASE‐2) Study	5
Contemporary Concise Review 2020: Asthma	5
Risk of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission during bronchoscopy in the intensive care unit	5
Device assessed activity behaviours in patients with indwelling pleural catheter: A sub‐study of the Australasian Malignant PLeural Effusion (AMPLE)‐2 randomized trial	5
Pulmonary vascular involvement in COVID‐19 pneumonitis: Is this the first and final insult?	5
Tocilizumab therapy in individuals with COVID‐19 infection and hyperinflammatory state	5
Mapping air pollution and idiopathic pulmonary fibrosis	5
Counting the cost of bronchiectasis	5
Identifying the asthma research priorities of people with asthma, their carers and other stakeholders	5
Variability of fractional exhaled nitric oxide is associated with the risk and aetiology of COPD exacerbations	5
Alveolar crystal burden in stone workers with artificial stone silicosis	5
Opportunities to diagnose fibrotic lung diseases in routine care: A primary care cohort study	5
Robotic bronchoscopic needle‐based confocal laser endomicroscopy to diagnose peripheral lung nodules	5
Prognosis assessment model based on low serum calcium in patients with acute pulmonary thromboembolism	5
Virtual bronchoscopic navigation and endobronchial ultrasound with a guide sheath without fluoroscopy for diagnosing peripheral pulmonary lesions with a bronchus leading to or adjacent to the lesion:	5
The unmet care needs of progressive fibrosing interstitial lung disease	5
Growth of the airway smooth muscle layer from late gestation to childhood is mediated initially by hypertrophy and subsequently hyperplasia	5
Letter from China: Response after the first wave of COVID‐19	5
Letter from China: Managing the second‐wave COVID‐19 outbreak in Beijing	5
Complications of rigid bronchoscopy	5
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	5
Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study	5
TSANZ Abstracts	5
Social distancing as a strategy to prevent respiratory virus infections	5
Effect of obstructive sleep apnoea on coronary collateral vessel development in patients with ST‐segment elevation myocardial infarction	5
Predictors of psychological stress in silica‐exposed workers in the artificial stone benchtop industry	5
3D printed airway simulators: Adding a dimension to bronchoscopy training	5
Concise guidance for COPD	5
Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic	5
Antibiotic‐resistant bacteria: COVID‐19 hasn't made the challenge go away	5
Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	5
Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes	5
Structural and functional changes in COPD: What we have learned from imaging	4
Pulmonary hypertension in Saudi Arabia: First data from the SAUDIPH registry with a focus on pulmonary arterial hypertension	4
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary	4
Assessing spirometry competence through certification in community‐based healthcare settings in Australia and New Zealand: A position paper of the Australian and New Zealand Society of Respiratory Sci	4
Targeting the human βc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure	4
Molecular testing of metastaticnon‐smallcell lung cancer in theAsia‐Pacificregion	4
Bayesian adaptive clinical trial designs for respiratory medicine	4
Severe COVID‐19 and interleukin‐6 receptor antagonist tocilizumab: Some notes of concern	4
Letter from Iran: Experiences with COVID‐19	4
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis	4
Probe‐based confocal laser endomicroscopy for pleural malignancies diagnosis	4
Value of adding ultrathin bronchoscopy to thin bronchoscopy for peripheral pulmonary lesions: A multicentre prospective study	4
Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines	4
Treatable traits for long COVID	4
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis	4
Abstracts	4
Treatable traits, combination inhaler therapy and the future of asthma management	4
A low exhaled nitric oxide level excludes a short‐term benefit from inhaled corticosteroids in suspected asthma: A randomized placebo‐controlled trial	4
Did you smoke? Addressing stigma in lung cancer	4
Circulating regulators of the wingless pathway in precapillary pulmonary hypertension	4
The 1918 influenza and COVID‐19 pandemics: The effect of age on outcomes	4
Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient	4
Cardiovascular and cerebrovascular mortality in patients with preceding asthma exacerbation	4